A two plasmid co-expression system in Escherichia coli for the production of virion-like reverse transcriptase of the human immunodeficiency virus type 1

被引:22
作者
Jonckheere, H [1 ]
DeVreese, K [1 ]
Debyser, Z [1 ]
Vandekerckhove, J [1 ]
Balzarini, J [1 ]
Desmyter, J [1 ]
De Clercq, E [1 ]
Anne, J [1 ]
机构
[1] STATE UNIV GHENT, PHYSIOL CHEM LAB, B-9000 GHENT, BELGIUM
关键词
HIV-1 reverse transcriptase; co-expression; RT subunits; drug sensitivity;
D O I
10.1016/0166-0934(96)02076-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Many bacterial expression systems have been developed to study the reverse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1). This enzyme exists in the virions as a heterodimer of a 66 kDa (p66) subunit and a 51 kDa (p51) subunit, originating through proteolytic maturation of the p66 subunit. Most expression systems rely on the processing of p66 by bacterial proteases, this results in a p51 subunit with a non-authentic carboxy-terminus. In contrast, the expression system described produces an RT with an authentic carboxy-terminus. This was achieved by the co-expression of the two subunits of HIV-1 RT, which were each cloned on a different, compatible plasmid in Escherichia coli, and by the use of protease inhibitors during cell lysis. This approach enabled us not only to obtain virion-like RT, as verified by mass spectrometry, but also to monitor the effect of mutations in one or both subunits on the activity of RT and on its sensitivity towards RT inhibitors. The co-expression system described represents a useful method to produce HIV-1 RT, both authentic and mutated, in quantities that allow large-scale studies on the functional organisation of the RT-subunits and the sensitivity of the enzyme to RT inhibitors.
引用
收藏
页码:113 / 125
页数:13
相关论文
共 33 条
  • [1] HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS SHOW DIFFERENTIAL ACTIVITY AGAINST HIV-1 MUTANT STRAINS CONTAINING DIFFERENT AMINO-ACID SUBSTITUTIONS IN THE REVERSE-TRANSCRIPTASE
    BALZARINI, J
    KARLSSON, A
    PEREZPEREZ, MJ
    VRANG, L
    WALBERS, J
    ZHANG, H
    OBERG, B
    VANDAMME, AM
    CAMARASA, MJ
    DECLERCQ, E
    [J]. VIROLOGY, 1993, 192 (01) : 246 - 253
  • [2] CHARACTERIZATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE ENZYME PRODUCED IN YEAST
    BATHURST, IC
    MOEN, LK
    LUJAN, MA
    GIBSON, HL
    FEUCHT, PH
    PICHUANTES, S
    CRAIK, CS
    SANTI, DV
    BARR, PJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 171 (02) : 589 - 595
  • [3] INCREASED YIELD OF HOMOGENEOUS HIV-1 REVERSE-TRANSCRIPTASE (P66/P51) USING A SLOW PURIFICATION APPROACH
    BHIKHABHAI, R
    CARLSSON, T
    UNGE, T
    LOVGREN, S
    STRANDBERG, B
    [J]. JOURNAL OF CHROMATOGRAPHY, 1993, 639 (01): : 67 - 74
  • [4] SUBUNIT SPECIFICITY OF MUTATIONS THAT CONFER RESISTANCE TO NONNUCLEOSIDE INHIBITORS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    BOYER, PL
    DING, JP
    ARNOLD, E
    HUGHES, SH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (09) : 1909 - 1914
  • [5] BIOCHEMICAL HETEROGENEITY OF REVERSE-TRANSCRIPTASE PURIFIED FROM THE AIDS VIRUS, HTLV-III
    CHANDRA, A
    GERBER, T
    CHANDRA, P
    [J]. FEBS LETTERS, 1986, 197 (1-2) : 84 - 88
  • [6] CONSTRUCTION AND CHARACTERIZATION OF AMPLIFIABLE MULTICOPY DNA CLONING VEHICLES DERIVED FROM P15A CRYPTIC MINIPLASMID
    CHANG, ACY
    COHEN, SN
    [J]. JOURNAL OF BACTERIOLOGY, 1978, 134 (03) : 1141 - 1156
  • [7] RESOLUTION OF MICROHETEROGENEITY ASSOCIATED WITH RECOMBINANT HIV-1 HETERODIMERIC REVERSE-TRANSCRIPTASE
    CHATTOPADHYAY, D
    EINSPAHR, HM
    BRUNNER, DP
    STRAKALAITIS, NA
    TARPLEY, WG
    DEIBEL, MR
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 1992, 3 (02) : 151 - 159
  • [8] DAQUILA RT, 1989, J ACQ IMMUN DEF SYND, V2, P579
  • [9] DEBYSER Z, 1993, MOL PHARMACOL, V43, P521
  • [10] DEBYSER Z, 1992, J BIOL CHEM, V267, P11769